BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1
25 results:

  • 1. LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
    Liu C; Shen A; Song J; Cheng L; Zhang M; Wang Y; Liu X
    Cancer Commun (Lond); 2024 Jan; 44(1):76-100. PubMed ID: 38010289
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A genetic variant in the immune-related gene ERAP1 affects colorectal cancer prognosis.
    Zou D; Cai Y; Jin M; Zhang M; Liu Y; Chen S; Yang S; Zhang H; Zhu X; Huang C; Zhu Y; Miao X; Wei Y; Yang X; Tian J
    Chin Med J (Engl); 2024 Feb; 137(4):431-440. PubMed ID: 37690994
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcription of human β-galactoside α2,6-sialyltransferase (hST6Gal I) is downregulated by curcumin through AMPK signaling in human colon carcinoma HCT116 cells.
    An SY; Kim KS; Lee YC; Kim SH
    Genes Genomics; 2023 Jul; 45(7):901-909. PubMed ID: 37231294
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer.
    Mastrogamvraki N; Zaravinos A
    NPJ Syst Biol Appl; 2020 Jul; 6(1):23. PubMed ID: 32737302
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. e2a attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway.
    Zhao H; Zhao C; Li H; Zhang D; Liu G
    J Exp Clin Cancer Res; 2019 Jun; 38(1):276. PubMed ID: 31234887
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS
    PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. SPDEF Induces Quiescence of colorectal cancer Cells by Changing the Transcriptional Targets of β-catenin.
    Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
    Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
    Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
    Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A dynamic exchange of tcf3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Hypomethylation-associated up-regulation of tcf3 expression and recurrence in stage II and III colorectal cancer.
    Li C; Cai S; Wang X; Jiang Z
    PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. e2a predicts prognosis of colorectal cancer patients and regulates cancer cell growth by targeting miR-320a.
    Huang A; Zhao H; Quan Y; Jin R; Feng B; Zheng M
    PLoS One; 2014; 9(1):e85201. PubMed ID: 24454819
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. e2a suppresses invasion and migration by targeting YAP in colorectal cancer cells.
    Zhao H; Huang A; Li P; Quan Y; Feng B; Chen X; Mao Z; Zhu Z; Zheng M
    J Transl Med; 2013 Dec; 11():317. PubMed ID: 24369055
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of tcf3 to be associated with the overall survival of colorectal cancer patients.
    Shao J; Lou X; Wang J; Zhang J; Chen C; Hua D; Mo F; Han X; Zheng S; Lin B
    PLoS One; 2013; 8(8):e70307. PubMed ID: 23940558
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
    Chiaro C; Lazarova DL; Bordonaro M
    Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TCF-3, 4 protein expression correlates with beta-catenin expression in MSS and MSI-H colorectal cancer from HNPCC patients but not in sporadic colorectal cancers.
    Balaz P; Plaschke J; Krüger S; Görgens H; Schackert HK
    Int J Colorectal Dis; 2010 Aug; 25(8):931-9. PubMed ID: 20532534
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer.
    Kijanka G; Hector S; Kay EW; Murray F; Cummins R; Murphy D; MacCraith BD; Prehn JH; Kenny D
    Gut; 2010 Jan; 59(1):69-78. PubMed ID: 19828471
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas.
    Geng LY; Shi ZZ; Dong Q; Cai XH; Zhang YM; Cao W; Peng JP; Fang YM; Zheng L; Zheng S
    World J Gastroenterol; 2007 Apr; 13(16):2305-11. PubMed ID: 17511028
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.
    Katoh M; Katoh M
    Cancer Biol Ther; 2006 Sep; 5(9):1059-64. PubMed ID: 16940750
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.